Ligustrazine Phosphate for Injection

This product has the effect of resisting platelet aggregation and disaggregating aggregated platelets. In addition, it can dilate arterioles, improve microcirculation and increase cerebral blood flow, thus producing the effects of anti-thrombosis and thrombolysis.

The main ingredient of this product is ligustrazine phosphate, and its chemical name is 2,3,5,6-tetramethylpyrazine phosphate monohydrate.

This product is white or off-white powder.

Used for ischemic cerebrovascular diseases, such as cerebral infarction caused by cerebral ischemia, cerebral thrombosis, and cerebral embolism.

Intravenous drip, 50-100 mg each time, diluted in 250-500 ml of 5%-10% glucose injection or sodium chloride injection, drip slowly, preferably within 3-4 hours. Once a day, 10-15 days as a course of treatment or follow the doctor's advice.

Stomach discomfort, dry mouth, drowsiness, etc. may occur occasionally, which can be relieved by reducing the dosage. Allergic reactions may occur occasionally.

1. Patients who are allergic to this product are prohibited from using it. 2. Patients with cerebral hemorrhage or bleeding tendency are prohibited from using it.

This product is highly acidic and should not be used in combination with alkaline drugs.

Keep away from light and store in a sealed container.

100mg

Suzhou Erye Pharmaceutical Co., Ltd.

• Founded in:

  1981-04-13

• Address:

  No. 2, Dongqiao Anmin Road, Huangdai Town, Xiangcheng District, Suzhou City

• Tax NO.:

  913205001377026284

• Registered Funds:

  300 million yuan

• Website:

  Log in to view

• Email:

  Log in to view